Rocket Lab makes little sense to buy over SpaceX, whose IPO is priced at a similar share price with far larger revenue. SpaceX targets $135 a share with $18.7B of revenue, while Rocket Lab trades at $115 with $600M. x.com 

Rocket Lab's roughly $80 billion valuation, including its newly announced $3 billion dilution, would require $3-4 billion in profit to be reasonable, and there is no scenario where it earns $3 billion within three years. The market can stay illogical longer than expected, so it could still run 50% before crashing 80%; the same applies to AST SpaceMobile. x.com  x.com 

Investors rotating into cheaper stocks with more upside should ultimately benefit Rocket Lab and AST SpaceMobile. Both have already suffered major drawdowns. x.com 

Rocket Lab still looks ridiculously expensive at 29 times forward sales against SpaceX at 22 times, even after a 65% fall. At 22 times, Rocket Lab would be roughly $38, and SpaceX would still be the pick. SpaceX also has better forward guidance; Rocket Lab's negative adjusted EBITDA makes sales multiples the valuation yardstick. x.com  x.com  x.com  x.com 

Rocket Lab could face a difficult 9-12 months because much of the space industry's future is already priced into equity valuations, even as its business and backlog grow. A monthly close below the $61 21-month EMA would raise the risk that the uptrend has ended and shift attention toward $35-45 for a better long-term entry; holding $61 preserves a more constructive reading. The company could still trade considerably higher over a longer horizon. x.com 

Good SpaceX earnings could help Rocket Lab lead the new-space sector higher with a rally as violent as its capitulation. Rocket Lab is the sector leader outside SpaceX; its RSI is extremely oversold, the lower Bollinger band is overstretched and MACD's negative divergence is subsiding. Three upside gaps lie at $55.25-59.18, $64.22-65.71 and $73.11-74.76. The highest should fill before year-end, though the exact date is hard to predict. x.com  x.com 

Rocket Lab, AST SpaceMobile and Intuitive Machines are priced as if they had already colonized the solar system, so they look headed one way once the hype rally ends. Together they carry an $82 billion market cap on $883 million of revenue and no profits, while burning cash heavily. Reusable rockets are a cost-reduction story rather than a giant leap. Their long-term potential may be real, but that future is 20-30 years out and does not justify today's valuations. x.com  x.com  x.com  x.com  x.com  … Show more

Rocket Lab, AST SpaceMobile, Firefly, Intuitive Machines, Redwire and SpaceX are too risky to buy at today's valuations, given the potential for a cascade decline. Index-inclusion buying may keep SpaceX and sympathy names bid for months, but in another growth bear market like 2021's aftermath they could fall hard and recover slowly even if the businesses execute, and SpaceX may eventually crash the party. They remain liked, just not worth adding; Northrop Grumman is the preferred space stock. … Show more

Rocket Lab completing its $1.94 billion ATM to fund the Iridium deal removes an overhang that likely suppressed the whole space sector. As the lead high-beta space name, its ATM selling in a thin, risk-off market was magnified by algos into AST SpaceMobile and peers; that pressure should now ease. After nearly four months of losses from the SpaceX IPO, macro risk-off, low summer liquidity and share sales, a base is starting to form. Delays or macro risk could still weigh. x.com  x.com  x.com 

Space stocks could regain high-beta flows as SpaceX lockups end and a probable late-November Anthropic IPO threatens AI stocks, much as SpaceX's IPO hurt space names. Hedge funds are overexposed to the Magnificent Seven and underexposed or max short low-quality high beta; falling rates and toppy oil could make the rotation painful for them through 2027. AST SpaceMobile could benefit as intermittent service triggers agreements and Blue Origin possibly returns to the pad in six weeks. x.com  x.com